Consumer Discretionary · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Nasdaq · CIK 1000228 · FYE Dec 26 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $85.83Day +0.14%Mkt cap $9.8BP/E (FY) 26.2×1Y +22.5%Off 52W high −3.9%Vol (1Y) 27.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,295 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Fair value (model)$31.98 |
| Implied upside−62.7% |
| Valuation confidenceMEDIUM |
| Price impliesAGGRESSIVE · 14.2% growth |
| Short interest5.7% of sh out |
| Days to cover5.0d |
| 13F net flow (QoQ)+0.05% |
| Top-10 13F concentration52.4% |
| Next report (est.)2026-08-04 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)26.2× |
| Sales (TTM)$13.38B |
| YTD+13.6% |
| 1Y+22.5% |
| 3Y+8.9% |
| 5Y+7.0% |
| 10Y+20.9% |
| Since incept. (ann.)+8.2% |
Total return through 2026-07-29 · series begins 2005-07-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)27.4% |
| Ann. volatility (3Y)26.2% |
| Sharpe (1Y)0.86 |
| Sharpe (3Y)0.23 |
| Max drawdown (1Y)−17.2% |
| Max drawdown (3Y)−24.3% |
| Beta (3Y vs SPY)0.78 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 15.7M | $1.2B | 13.74% | +0.0% |
| BlackRock, Inc. | 7.0M | $518M | 6.17% | +0.9% |
| Artisan Partners Limited Partnership | 6.6M | $484M | 5.77% | −1.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.4M | $473M | 5.64% | new |
| FMR LLC | 5.7M | $422M | 5.02% | +44.0% |
| Invesco Ltd. | 4.9M | $360M | 4.29% | +9.7% |
| JPMORGAN CHASE & CO | 4.6M | $332M | 4.01% | −10.6% |
| STATE STREET CORP | 4.4M | $323M | 3.84% | −0.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 105.6% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 7,220,104 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-28 | 2026-05-05 | $0.92 | +4.5% | $3.37B | +6.3% |
| 2025-12-27 | 2026-02-24 | — | — | $3.44B | +7.7% |
| 2025-09-27 | 2025-11-04 | $0.84 | +7.7% | $3.34B | +5.2% |
| 2025-06-28 | 2025-08-05 | $0.70 | −12.5% | $3.24B | +3.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Global Distribution And Value Added Services 84% · Global Specialty Products 11% · Global Technology 5%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Earnings (TTM)$395.0M |
| ROE12.0% |
| Net margin3.0% |
| EPS growth 3Y−5.8% |
| Sales growth 3Y1.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
